OCT-Guided Stent Implantation, IVUS, and Angiography-Guided PCI Compared
By MedImaging International staff writers Posted on 04 Sep 2015 |
A medical device vendor has announced the launch of a clinical study to compare intravascular assessments and Percutaneous Coronary Intervention (PCI) during stent implantation, using guidance by Optical Coherence Tomography (OCT), Intravascular Ultrasound (IVUS) or only angiography.
The ILUMIEN III multicenter randomized study is intended to improve the standard of care for cardiovascular patients by using OCT technology to enable clinicians to provide anatomical images of disease morphology, and automatically measure vessel characteristics that are difficult to assess using IVUS or angiography. The measurements are needed for stent selection, stent deployment, and placement, and can decrease the risk of repeated revascularization.
The OCT technique was developed by St. Jude Medical (St. Paul, MN, USA). Clinicians will use St. Jude’s Optis Integrated and ILUMIEN Optis PCI optimization systems for the study. The study will include up to 420 patients from Europe, the US, and Japan.
Clinicians use diagnostic imaging during PCI procedures to decide on the size of the required stent, and increase the minimal stent area (MSA). This revascularization procedure ensures that the stent expands enough during PCI to restore blood flow.
Dr. Mark Carlson, chief medical officer at St. Jude Medical, said, “The launch of ILUMIEN III is an important step in assessing St. Jude Medical’s OCT technology and its ability to improve stent implantation over first generation diagnostic tools. The study builds on important research showing the benefits of OCT imaging in supporting clinical decision making, and we’re excited to have this important trial underway.”
Related Links:
St. Jude Medical
The ILUMIEN III multicenter randomized study is intended to improve the standard of care for cardiovascular patients by using OCT technology to enable clinicians to provide anatomical images of disease morphology, and automatically measure vessel characteristics that are difficult to assess using IVUS or angiography. The measurements are needed for stent selection, stent deployment, and placement, and can decrease the risk of repeated revascularization.
The OCT technique was developed by St. Jude Medical (St. Paul, MN, USA). Clinicians will use St. Jude’s Optis Integrated and ILUMIEN Optis PCI optimization systems for the study. The study will include up to 420 patients from Europe, the US, and Japan.
Clinicians use diagnostic imaging during PCI procedures to decide on the size of the required stent, and increase the minimal stent area (MSA). This revascularization procedure ensures that the stent expands enough during PCI to restore blood flow.
Dr. Mark Carlson, chief medical officer at St. Jude Medical, said, “The launch of ILUMIEN III is an important step in assessing St. Jude Medical’s OCT technology and its ability to improve stent implantation over first generation diagnostic tools. The study builds on important research showing the benefits of OCT imaging in supporting clinical decision making, and we’re excited to have this important trial underway.”
Related Links:
St. Jude Medical
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection